| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9B | $9.7B | $9.8B | $10.2B | $11.0B | $2.9B | $3.7B | $3.5B |
| Cost of Revenue | $2.4B | $2.3B | $2.5B | $2.3B | $2.1B | $1.8B | $2.0B | $1.8B |
| Gross Profit | — | — | — | — | — | $2.4B | $3.2B | $3.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.4B | $2.4B | $2.5B | $2.4B | $2.7B | $2.5B | $2.4B | $2.1B |
| Operating Income | — | — | — | — | $2.8B | $4.6B | $7.0B | $5.9B |
| Net Income | $1.3B | $1.6B | $1.2B | $3.0B | $1.6B | $0.4B | $1.4B | $0.9B |
| EPS (Basic) | $8.83 | $11.21 | $8.02 | $20.96 | $10.44 | $2.33 | $8.10 | $4.74 |
| EPS (Diluted) | $8.79 | $11.18 | $7.97 | $20.87 | $10.40 | $2.32 | $8.08 | $4.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.4B | $28.0B | $26.8B | $24.6B | $23.9B | $24.6B | $27.2B | $25.3B |
| Current Assets | $9.0B | $7.5B | $6.9B | $9.8B | $7.9B | $6.9B | $8.4B | $7.6B |
| Cash & Equivalents | — | — | — | — | — | — | $2.9B | $1.2B |
| Total Liabilities | $11.2B | $11.3B | $12.0B | $11.2B | $12.9B | $13.9B | $13.9B | $12.3B |
| Current Liabilities | $3.3B | $5.5B | $3.4B | $3.3B | $4.3B | $3.7B | $4.9B | $3.3B |
| Stockholders' Equity | — | — | $14.8B | $13.4B | $10.9B | $10.7B | $13.3B | $13.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $2.9B | $1.5B | $1.4B | $3.6B | $4.2B | $7.1B | $6.2B |
| Investing Cash Flow | $-1.4B | $-0.8B | $-4.1B | $1.6B | $-0.6B | $-0.6B | $0.5B | $-2.0B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.2B | $0.3B | $0.4B | $0.5B | $0.8B |
| Financing Cash Flow | $-0.3B | $-0.7B | $0.1B | $-1.7B | $-2.1B | $-5.3B | $-5.9B | $-4.5B |